This HTML5 document contains 139 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1517/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38770171
rdf:type
wikibase:Item
schema:description
2016 թվականի մարտի 11-ին հրատարակված գիտական հոդված научна статия мақолаи илмӣ artigo científico vedecký článok vetenskaplig artikel 2016年論文 articolo scientifico наукова стаття, опублікована в березні 2016 article scientific wissenschaftlicher Artikel artículu científicu espublizáu en 2016 2016年论文 bilimsel makale 2016년 논문 2016年論文 artikulong pang-agham tudományos cikk επιστημονικό άρθρο naučni članak article scientifique სამეცნიერო სტატია vědecký článek научная статья 2016年論文 2016年论文 tieteellinen artikkeli מאמר מדעי 2016年论文 scientific article published on 11 March 2016 2016年論文 vitenskapelig artikkel articol științific ১১ মার্চ ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ teaduslik artikkel научни чланак 2016年论文 artículo científico publicado en 2016 artigo científico vitskapeleg artikkel 2016年論文 scientific article published on 11 March 2016 videnskabelig artikel wetenschappelijk artikel 2016年论文 artikel ilmiah artigo científico bài báo khoa học scientific article published on 11 March 2016 2016年の論文 artikull shkencor научни чланак 2016年论文 artykuł naukowy 2016 nî lūn-bûn article científic บทความทางวิทยาศาสตร์ مقالة علمية نشرت في 11 مارس 2016 scienca artikolo
p:P577
wds:Q38770171-7E792D26-66F8-45ED-A286-22C9E3C17E7B
wdt:P577
2016-03-11T00:00:00Z
p:P407
wds:Q38770171-C121A259-C37A-46C8-81BE-EB48A1DD29E3
wdt:P407
wd:Q1860
p:P2860
wds:Q38770171-47C1EE50-A16E-46DC-983D-A6AFF15A6986 wds:Q38770171-4D43925D-97F5-4B95-88FF-35138ACD1B19 wds:Q38770171-59986E7F-506B-43B5-9B3F-2B3AAE9C5860 wds:Q38770171-5CEBF276-3559-4377-A0F6-10C8CD97E6B8 wds:Q38770171-6A2BE3A7-1653-4A83-9099-03516154CBB2 wds:Q38770171-6C70B787-81E8-48C2-A83E-B17F4FD5DB46 wds:Q38770171-8808FB8C-EF16-4FE7-B403-990AB3A5D222 wds:Q38770171-906FE45A-F54D-4ACF-AE61-0A6923FCF163 wds:Q38770171-95101FCF-2D81-47D0-A83F-8D08E6C01DE7 wds:Q38770171-A03B4E5A-3FFC-4C65-9A93-DB052845BF17 wds:Q38770171-B907A2C0-37F4-4131-8149-2906D9E66ECD wds:Q38770171-BE9D8DB8-54EF-49A4-B790-D21A214B0519 wds:Q38770171-D49891AE-FA03-4240-83CB-B7054AF673C6 wds:Q38770171-D68F92F6-D6B6-4E9F-91A1-9DF3540A54B4 wds:Q38770171-F3B2F21E-2979-45DF-A19C-BDE3E258E92B wds:Q38770171-0C6FEF14-E8D9-497D-B4F1-9AFB2E7A0937 wds:Q38770171-0F516148-AE04-42C3-9E58-DB5D0B18EADF wds:Q38770171-12D6AFE6-0C12-4251-A80D-411FA9AE0985 wds:Q38770171-1D78CEA1-6EEE-49D2-B381-DFD8DD55AFCF wds:Q38770171-2C041CA3-16C6-4A9E-B0B0-9624E8783248 wds:Q38770171-43C3EC8B-B92E-43E8-B4FD-A733F3FED569 wds:Q38770171-475221A8-C3EC-4C86-B400-F9FE5ED86964
wdt:P2860
wd:Q35591553 wd:Q30978102 wd:Q38033462 wd:Q51606129 wd:Q46876526 wd:Q28250200 wd:Q34132007 wd:Q41703064 wd:Q34339563 wd:Q34748891 wd:Q51562771 wd:Q24644303 wd:Q36609344 wd:Q22299423 wd:Q24624885 wd:Q38094297 wd:Q36212667 wd:Q36269320 wd:Q35743348 wd:Q38214213 wd:Q34665000 wd:Q51465407
p:P2093
wds:Q38770171-6C560D21-D7C1-4D8E-A723-C3E3A0E1F1E9
wdt:P2093
Susanna A McColley
rdfs:label
A safety evaluation of ivacaftor for the treatment of cystic fibrosis A safety evaluation of ivacaftor for the treatment of cystic fibrosis A safety evaluation of ivacaftor for the treatment of cystic fibrosis
skos:prefLabel
A safety evaluation of ivacaftor for the treatment of cystic fibrosis A safety evaluation of ivacaftor for the treatment of cystic fibrosis A safety evaluation of ivacaftor for the treatment of cystic fibrosis
schema:name
A safety evaluation of ivacaftor for the treatment of cystic fibrosis A safety evaluation of ivacaftor for the treatment of cystic fibrosis A safety evaluation of ivacaftor for the treatment of cystic fibrosis
p:P1476
wds:Q38770171-0A989962-4C0B-4DCE-B09F-4249117B2BB9
wdt:P1476
A safety evaluation of ivacaftor for the treatment of cystic fibrosis
p:P304
wds:Q38770171-AF2D6B3F-C76E-4C47-B562-78FDEA27B26F
wdt:P304
709-715
p:P31
wds:Q38770171-0CE23701-968C-48F5-9B62-9B1D715E3518
wdt:P31
wd:Q13442814
p:P921
wds:Q38770171-2BADC7FC-36E4-453A-B659-510A40A728A7
wdt:P921
wd:Q178194
p:P698
wds:Q38770171-FBAEDAF4-93D2-4DCF-9B21-D730C77111DD
wdtn:P698
n11:26968005
wdt:P698
26968005
p:P1433
wds:Q38770171-4721A8DA-C0EA-4FEE-9E75-7874AE608266
wdt:P1433
wd:Q5421206
p:P433
wds:Q38770171-12A8EED0-79D8-48FF-9B15-A58B4806D4C8
p:P478
wds:Q38770171-146F468F-6C26-4C7B-8728-BEE3840141B4
wdt:P433
5
wdt:P478
15
p:P356
wds:Q38770171-38F3BD11-8C70-462E-820B-8FDF7A2AB0FF
wdtn:P356
n10:14740338.2016.1165666
wdt:P356
10.1517/14740338.2016.1165666